Loading data
BBLGNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 1.06 m USD | 2.13 m USD | 6.91 m USD | 1.58 m USD | 82.04 k USD |
| Operating profit | -3.23 m USD | -4.22 m USD | -9.43 m USD | -3.67 m USD | -1.1 m USD |
| Net income (reported basis) | -3.11 m USD | -4.11 m USD | -8.95 m USD | -1.48 m USD | -1.61 m USD |
| Net income attributable to common shareholders | -3.11 m USD | -7.32 m USD | -8.95 m USD | — | — |
| Basic earnings per share | -2.65 USD/share | -28.96 USD/share | -34.01 USD/share | -31.15 USD/share | -0.35 USD/share |
| Diluted earnings per share | -2.65 USD/share | -28.96 USD/share | -34.01 USD/share | -31.15 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.